Low Expression of Long Noncoding RNA IRAIN Is Associated with Poor Prognosis in Non-M3 Acute Myeloid Leukemia Patients-Reference-Cited by-同舟云学术

Low Expression of Long Noncoding RNA IRAIN Is Associated with Poor Prognosis in Non-M3 Acute Myeloid Leukemia Patients

Published:2018-05 Issue:5 Volume:22 Page:288-294
ISSN:1945-0265
Container-title:Genetic Testing and Molecular Biomarkers
language:en
Short-container-title:Genetic Testing and Molecular Biomarkers

Author:

Pashaiefar Hossein¹,Izadifard Marzieh²,Yaghmaie Marjan¹,Montazeri Maryam¹,Gheisari Elahe¹,Ahmadvand Mohammad¹,Momeny Majid¹,Ghaffari Seyed Hamid¹,Kasaeian Amir¹,Alimoghaddam Kamran¹,Ghavamzadeh Ardeshir¹

Affiliation:

1. Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran.

2. Department of Genetics, Payame Noor University of Rey, Tehran, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical),General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/gtmb.2017.0281

Reference23 articles.

1. Aberrant microRNA expression and its implications in the pathogenesis of leukemias

2. Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia

3. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

4. Acute myeloid leukaemia in adults

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non‐coding RNA as potential diagnostic markers for acute myeloid leukemia: A systematic review and meta‐analysis;Cancer Medicine;2024-06

2. LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-κB/CD44 pathway inhibition;iScience;2024-06

3. Long non-coding RNAs: emerging functional players in the pathobiology and progression of myeloid leukemia;Frontiers in RNA Research;2024-05-31

4. Upregulation of lnc-FOXD2-AS1, CDC45, and CDK1 in patients with primary non-M3 AML is associated with a worse prognosis;Blood Research;2024-02-19

5. Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target;Aspects of Molecular Medicine;2023-12